25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols

25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols

Overview of Adverse Contrast Reactions

Intravascular administration of iodinated radiopaque contrast media (ROCM) carries an inherent risk of adverse clinical reactions. Although the widespread adoption of non-ionic Low-Osmolar Contrast Media (LOCM) and Isosmolar Contrast Media (IOCM) has reduced overall reaction rates from $\sim 12%$ (with ionic HOCM) to less than $1.5%$, unpredictable and severe life-threatening reactions continue to occur.

The radiologic technologist (RadTech) is often the first healthcare provider to recognize early clinical signs of an adverse contrast reaction. Immediate recognition, precise classification of severity, rapid notification of the radiologist, and swift execution of emergency medical protocols are critical competencies for patient survival.

---

Reaction Mechanisms: Idiosyncratic vs. Non-Idiosyncratic

Adverse contrast reactions are broadly categorized into two fundamental pathophysiological mechanisms: idiosyncratic (anaphylactoid) and non-idiosyncratic (chemotoxic).

+-------------------------------------------------------------------------+
|                    CONTRAST REACTION MECHANISMS                         |
+------------------------------------+------------------------------------+
|   IDIOSYNCRATIC (ANAPHYLACTOID)    |   NON-IDIOSYNCRATIC (CHEMOTOXIC)   |
|  - Unpredictable & Independent of  |  - Dose & Concentration Dependent  |
|    Dose or Concentration           |  - Direct Chemotoxicity & High     |
|  - Mimics Type I IgE Anaphylaxis   |    Osmolality Effects              |
|  - Direct Mast Cell / Basophil     |  - Hemodynamic Shifts & Organ      |
|    Histamine Release               |    Toxicity                        |
|  - Examples: Hives, Bronchospasm,  |  - Examples: Warmth, Nausea,       |
|    Laryngeal Edema, Shock          |    Bradycardia, CIN, Seizures      |
+------------------------------------+------------------------------------+

1. Idiosyncratic (Anaphylactoid / Pseudo-Allergic) Reactions

• Pathophysiology: Idiosyncratic reactions mimic true Type I IgE-mediated immediate hypersensitivity reactions, but they do not depend on prior antigen sensitization or antibody formation. Contrast media directly trigger non-IgE degranulation of tissue mast cells and circulating basophils, releasing inflammatory mediators such as histamine, bradykinin, leukotrienes, and prostaglandins.
• Key Feature: Completely unpredictable and independent of contrast dose, volume, or rate of injection. A minute test dose of $1 \ ext{ mL}$ can trigger fatal anaphylactic shock just as readily as a $100 \ ext{ mL}$ bolus.
• Clinical Signs: Urticaria (hives), pruritus, angioedema, bronchospasm, laryngeal edema, and anaphylactic shock.

2. Non-Idiosyncratic (Chemotoxic / Physiological) Reactions

• Pathophysiology: Non-idiosyncratic reactions are caused by the direct physical and chemical properties of the contrast agent, including high osmolality, chemical cytotoxicity, binding to plasma proteins, and ion imbalances (such as calcium chelation).
• Key Feature: Strictly dose-dependent and concentration-dependent. The severity of symptoms increases directly with larger volumes, higher iodine concentrations, and rapid injection rates.
• Clinical Signs: Sensation of intense warmth/flushing, metallic taste in the mouth, nausea, vomiting, vasovagal responses (bradycardia and hypotension), cardiac arrhythmias, contrast-induced nephropathy (CIN), and seizures resulting from blood-brain barrier disruption.

3. Patient Risk Factors & Pre-Medication Protocols

• High-Risk Profiles:
  • History of prior adverse reaction to iodinated contrast (single greatest risk factor, increasing reaction risk 5-fold).
  • History of severe asthma or active bronchospasm.
  • History of severe food or drug allergies (multiple severe allergies).
  • Underlying cardiac disease, dehydration, renal impairment, or extreme age.
  • Note: A history of seafood or shellfish allergy was historically thought to indicate contrast allergy; modern evidence proves there is no cross-reactivity between iodine/contrast and shellfish tropomyosin. Shellfish allergy merely reflects a general allergic predisposition.
• Elective Pre-medication Protocol (ACR 13-Hour Regimen): When contrast administration is medically necessary in a patient with a documented prior anaphylactoid contrast reaction, elective premedication suppresses mast cell degranulation:
  1. Oral Prednisone: $50 \ ext{ mg}$ PO given at 13 hours, 7 hours, and 1 hour prior to contrast administration.
  2. Oral / IV Diphenhydramine (Benadryl): $50 \ ext{ mg}$ PO or IV given 1 hour prior to contrast administration.
  3. Accelerated Emergency Protocol (IV): Methylprednisolone (Solu-Medrol) $40 \ ext{ mg}$ IV every 4 hours until contrast study, plus Diphenhydramine $50 \ ext{ mg}$ IV 1 hour prior (minimum 4-hour lead time).

---

Severity Classification of Adverse Contrast Reactions

Adverse reactions are classified into three severity levels: Mild, Moderate, and Severe. Prompt recognition of clinical signs is essential to prevent rapid progression from mild symptoms to life-threatening collapse.

1. Mild Contrast Reactions

• Characteristics: Non-life-threatening, self-limiting, and resolve without permanent sequelae. Require reassurance and close observation.
• Clinical Manifestations:
  • Sensation of generalized body warmth or flushing
  • Metallic taste in the mouth
  • Mild nausea or isolated vomiting
  • Localized mild urticaria (hives) or cutaneous pruritus (itchiness)
  • Mild nasal congestion, sneezing, or throat clearing
  • Mild lightheadedness or anxiety

2. Moderate Contrast Reactions

• Characteristics: Non-life-threatening initially, but cause significant patient distress and require prompt medical evaluation, close monitoring, and targeted pharmacological intervention to prevent progression.
• Clinical Manifestations:
  • Widespread or diffuse urticaria (extensive hives) and intense pruritus
  • Moderate bronchospasm, wheezing, or mild dyspnea
  • Facial, periorbital, or tongue swelling (angioedema) without airway compromise
  • Tachycardia ($> 100 \ ext{ bpm}$) or sinus bradycardia ($< 60 \ ext{ bpm}$) with stable blood pressure
  • Moderate hypotension ($SBP > 90 \ ext{ mmHg}$ but dropping)
  • Severe or protracted vomiting

3. Severe Contrast Reactions

• Characteristics: Potentially fatal, life-threatening emergency events that demand immediate emergency code activation (Code Blue / EMS) and aggressive resuscitation.
• Clinical Manifestations:
  • Severe bronchospasm, severe dyspnea, cyanosis, and hypoxia
  • Laryngeal edema presenting as inspiratory stridor and progressive upper airway obstruction
  • Profound hypotension ($SBP < 80 \ ext{ mmHg}$) combined with tachycardia (anaphylactic shock)
  • Severe bradycardia ($< 50 \ ext{ bpm}$) combined with profound hypotension (severe vasovagal reaction)
  • Unresponsiveness, loss of consciousness, convulsions/seizures
  • Cardiac arrest or lethal ventricular arrhythmias

---

Emergency Treatment Protocols & Pharmacological Interventions

Every radiologic facility must maintain a fully stocked emergency crash cart and oxygen delivery equipment in the imaging suite. The table below outlines the definitive step-by-step treatment protocols for each severity tier:

---

Detailed Emergency Drug Protocols

1. Epinephrine (Adrenaline) — The Primary Life-Saving Drug

Epinephrine is the absolute first-line pharmacological agent for severe anaphylactoid reactions, severe bronchospasm, laryngeal edema, and anaphylactic shock.

• Mechanism: Stimulates $\alpha_1$-adrenergic receptors (causing vasoconstriction to reverse profound hypotension and mucosal edema) and $\beta_1/\beta_2$-adrenergic receptors (causing bronchodilation and increasing cardiac output).
• Concentration & Route:
  • Intramuscular (IM): Concentration 1:1,000 (1 mg/mL). Administer 0.3 mg (0.3 mL) IM into the anterolateral mid-thigh (vastus lateralis muscle). Preferred route for non-arrest anaphylaxis due to rapid absorption and safety. May repeat every 5 to 15 minutes.
  • Intravenous (IV): Concentration 1:10,000 (0.1 mg/mL). Used only during cardiac arrest or profound shock refractory to IM injections, administered as slow IV push ($0.1 \ ext{ to } 0.3 \ ext{ mg}$) under continuous cardiac monitoring by a physician.

2. Atropine Sulfate — For Severe Bradycardia & Hypotension (Vasovagal Reaction)

• Indication: Profound vasovagal reaction characterized by bradycardia ($< 50 \ ext{ bpm}$) accompanied by hypotension ($SBP < 90 \ ext{ mmHg}$).
• Mechanism: Parasympatholytic anticholinergic agent that blocks vagal nerve tone on the sinoatrial (SA) node, restoring normal heart rate.
• Dosage & Route: 0.6 to 1.0 mg IV push, repeated every 3 to 5 minutes up to a maximum total dose of 3.0 mg ($0.04 \ ext{ mg/kg}$).

3. Diphenhydramine (Benadryl) — Antihistamine

• Indication: Symptomatic mild-to-moderate cutaneous allergic reactions (urticaria, pruritus, angioedema).
• Mechanism: $H_1$-receptor antagonist that blocks histamine binding sites.
• Dosage & Route: 25 to 50 mg IV or IM (slow IV push over 1–2 minutes). Note: Diphenhydramine does not replace epinephrine in severe anaphylaxis or airway compromise.

4. Bronchodilators (Albuterol)

• Indication: Isolated mild-to-moderate bronchospasm and wheezing with stable blood pressure.
• Dosage & Route: Albuterol meter-dose inhaler (2 to 3 puffs) or $2.5 \ ext{ mg} / 3 \ ext{ mL}$ nebulizer solution via oxygen mask.

5. Intravenous Fluids (Isotonic $0.9%$ Normal Saline)

• Indication: Profound hypotension and distributive anaphylactic shock caused by systemic capillary leakage and vasodilation.
• Administration: Rapid bolus infusion of $1 \ ext{ to } 2 \ ext{ Liters}$ of $0.9%$ Normal Saline or Ringer's Lactate under pressure.